Últimas noticias sobre NuCana (NASDAQ:NCNA) Bolsa

NuCana

NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.

Pinterest,Mobile,App,On,The,Screen,Smartphone,Iphone,Closeup.,Pinterest

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

CETY

CRVS

FIGS

GDOT

GMED

IOVA

JBIO

NCNA

PINS

PROF

SHPH

TMDX

VEEE

WOLF

WORX

ZKIN

Pinterest sube un 12,7 % tras superar ingresos del primer trimestre y aumentar usuarios mensuales. Otras acciones también reaccionan.

Acciones de Pinterest (PINS) se disparan un 13%; Aquí están 20 acciones que se mueven en el premercado

NuCana PLC

Shell (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHEL#NYSE">SHEL</a>) has outperformed the market over the past 5 years by 2.46% on an annualized basis producing an average annual return of 16.66%. Currently, Shell has a market capitalization of $208.65 billion. 
Buying $100 In SHEL: If an investor had bought $100 of SHEL stock 5 years ago, it would be worth $212.37 today based on a price of $71.10 for SHEL at the time of writing.
<h3>Shell's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1752529513_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

SHEL

Here's How Much You Would Have Made Owning Shell Stock In The Last 5 Years

<a href="https://www.bloomberg.com/news/articles/2025-07-14/trump-moves-to-impose-17-tariff-on-most-mexican-tomato-imports">https://www.bloomberg.com/news/articles/2025-07-14/trump-moves-to-impose-17-tariff-on-most-mexican-tomato-imports</a>

General

'Trump Moves to Impose 17% Tariff on Most Mexican Tomato Imports'- Bloomberg

<a href="https://www.bloomberg.com/news/articles/2025-07-14/lockheed-clears-backlog-of-f-35s-parked-over-software-woes">https://www.bloomberg.com/news/articles/2025-07-14/lockheed-clears-backlog-of-f-35s-parked-over-software-woes</a>

'Lockheed Clears 72-Jet Backlog of F-35s Parked Over Late Software Improvements'- Bloomberg

Offerings

DUOT

Duos Technologies Files For Prospectus Offering 4.8M Common Stock Offered By Selling Stockholders

Franco-Nevada (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FNV#NYSE">FNV</a>) has outperformed the market over the past 10 years by 3.21% on an annualized basis producing an average annual return of 14.64%. Currently, Franco-Nevada has a market capitalization of $30.52 billion. 
Buying $1000 In FNV: If an investor had bought $1000 of FNV stock 10 years ago, it would be worth $3,998.49 today based on a price of $158.50 for FNV at the time of writing.
<h3>Franco-Nevada's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1752528618_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In Franco-Nevada 10 Years Ago Would Be Worth This Much Today

LQR House Files For Common Stock Offering Of $46M

Waters Corp Says Merger Agreement Requires Co To Pay BD Termination Fee Of $733M If Agreement Is Terminated Under Certain Circumstances

MicroStrategy Incorporated&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) <a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46401183/strategy-adds-472-million-in-bitcoin-ups-total-holdings-to-over-600000-btc">is trading higher</a> Monday. It may be breaking the resistance that has been around the $441.50 level.
We have made MicroStrategy our Stock of the Day because breakouts tend to be bullish. There is a good chance it will be followed by a move higher.
Successful traders understand market psychology. For example, they know that one of the reasons why resistance forms is due to remorseful buyers trying to sell. People buy stocks and then regret doing so if price drops after.
Some of them decide that they will hold onto these losing positions, but they also decide that if they can eventually do so, they will exit at breakeven. So, if the stock rallies back up to their buying price they will sell.
If there is a large amount of these sell orders, it will create resistance.
Read Also: <a href="https://www.benzinga.com/trading-ideas/previews/25/07/46403464/jpmorgan-q2-preview-a-banking-renaissance-on-the-horizon">JPMorgan Q2 Preview: A &#8216;Banking Renaissance&#8217; On The Horizon</a>
As you can see on the chart, there was resistance for MicroStrategy around $441.40 in November and December. Each time the stock reached this level, it reversed and went lower. When this happened, some of the people who bought shares while the stock was at the resistance decided that buying was a mistake.
So when MicroStrategy recently returned to this level, selling by these remorseful sellers created resistance at the price again.
If the stock can get and hold above this resistance, traders will say it's a ‘breakout'.
This isn't just symbolic. It illustrates an important supply and demand dynamic. It could mean that the traders and investors who created the resistance with their sell orders are out of the way.
They have either finished or canceled their orders.
Regardless of the market, if supply (sellers) is taken out of it, the demand side (buyers) will be forced to be aggressive if they want their orders to be executed.
Buyers will cut ahead of each other and outbid each other in order to draw sellers back into the market. This could force the stock into an uptrend. It may be about to happen with MicroStrategy.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46397545/nvidias-jensen-huang-china-doesnt-need-us-chips">Nvidia&#8217;s Jensen Huang: China Doesn&#8217;t Need US Chips</a></li>
</ul>
Image: Shutterstock

Equities

Technicals

MSTR

Stock Of The Day – Breakout Time For MicroStrategy?

<a href="https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20250714-1478894/1478894_5-anss.pdf">https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20250714-1478894/1478894_5-anss.pdf</a>

ANSS

The Trade Desk Will Replace Ansys In The S&P 500 Effective Prior To The Opening Of Trading On Friday, July 18

BTBT

Bit Digital Expects Preliminary Revenue For Q2 2025 At $24.3M-$26.9M

Bit Digital, Inc. (NASDAQ:<a href="https://www.benzinga.com/stock/BTBT#NASDAQ">BTBT</a>) ("Bit Digital" or the "Company") today announced that it has entered into a placement agency agreement with B. Riley Securities, Inc. (the "Placement Agent") for the purchase and sale of&nbsp;22&nbsp;million ordinary shares at an offering price of $3.06 per share, pursuant to a registered direct offering to certain institutional investors, expected to result in gross proceeds to the Company of approximately $67.3 million, before deducting placement agent fees and offering expenses. The offering is expected to close on or about July 15, 2025, subject to the satisfaction of customary closing conditions.
The Company intends to use the net proceeds from the proposed offering to purchase&nbsp;Ethereum.
B. Riley Securities is acting as the exclusive Placement Agent for the offering.

Bit Digital, Inc. Announces $67.3M Registered Direct Offering Of 22M Shares At A Price Of $3.06/Share

Firefly Aerospace, a Texas-based company specializing in space transportation, has submitted paperwork for an initial public offering and intends to list its shares on the Nasdaq<a href="https://www.benzinga.com/news/space/25/07/46397540/space-stock-watch-spacex-prepares-launch-for-project-kuiper-jim-cramer-calls-rocket-lab-a-buy"> under the ticker "FLY."</a>
<h3 class="wp-block-heading">Market Context</h3>
Firefly's IPO comes at a time when public offerings are making a comeback after a sharp downturn in 2022, according to <a href="https://www.cnbc.com/2025/07/11/firefly-files-to-ipo.html">CNBC.</a> 
Read Next:<a href="https://www.benzinga.com/news/health-care/25/07/46355532/unitedhealth-hits-reset-new-head-of-medicaid-appointed-as-ceo-reshapes-team?utm_source=articleShare"> UnitedHealth Hits Reset: New Head Of Medicaid Appointed As CEO Reshapes Team</a>&nbsp;
Earlier this year, some firms such as Klarna and StubHub postponed their own IPOs due to uncertainty in global markets linked to President Donald Trump's tariff policies.&nbsp;
However, investor sentiment has improved recently, with a busy June for venture capital activity. Figma also filed its prospectus this month.
<h3 class="wp-block-heading">Company Overview</h3>
Firefly Aerospace develops rockets, space tugs and lunar landers, and is particularly recognized for its Alpha rockets, which are used to launch satellites.&nbsp;
The company achieved a milestone earlier this year when its Blue Ghost lunar lander successfully touched down on the moon.
<h3 class="wp-block-heading">Financial Highlights</h3>
<ul class="wp-block-list">
<li>Revenue: Increased more than sixfold to approximately $55.9 million by the end of March, up from $8.3 million a year earlier.</li>
<li>Net Loss: Reported a net loss of about $60.1 million, compared to $52.8 million the previous year.</li>
<li>Backlog: The company's backlog stands at around $1.1 billion.</li>
</ul>
<h3 class="wp-block-heading">Why It Matters</h3>
The U.S. IPO market is showing renewed strength,<a href="https://www.benzinga.com/markets/ipos/25/06/45941185/chimes-ipo-marks-another-successful-wall-street-debut"> highlighted by several </a>high-profile debuts in recent weeks.&nbsp;
Chime Financial, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHYM#NASDAQ">CHYM</a>) made headlines with its initial public offering, as shares soared by as much as 66% on the first day of trading. Chime opened at $43 per share—well above its $27 IPO price—before closing at around $37. The offering raised $864 million, and at its peak, Chime's valuation reached approximately $18.4 billion.
Other recent IPOs have also delivered impressive performances. Circle Internet Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRCL#NYSE">CRCL</a>) was priced at $31, but shares skyrocketed to $88 on the first day and surpassed $107 the next, marking a two-day surge of nearly 250%.&nbsp;
CoreWeave, Inc. (CRWV) debuted at $40 per share in late March and was trading around $132 Monday, up nearly 230%, with a market cap exceeding $60 billion.
The recent strong debuts suggest growing investor confidence and a revitalized IPO landscape ahead of Firefly's listing.&nbsp;
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/politics/25/07/46308025/get-ready-for-800-hours-of-blackouts-trumps-doe-warns?utm_source=articleShare">Get Ready For 800 Hours Of Blackouts, Trump&#8217;s DOE Warns</a>&nbsp;</li>
</ul>
Photo courtesy of Firefly Aerospace

SPACE

IPOs

Tech

CHYM

CRCL

CRWV

Firefly Aerospace Sets Sights On Nasdaq After Moon Landing Success

Palantir Technologies Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) shares closed Monday at their highest levels ever and have now nearly doubled since the start of the year. Here&#8217;s a look at what&#8217;s been fueling the momentum in the <a href="https://www.benzinga.com/trading-ideas/movers/25/07/46398720/palantir-stock-is-gaining-again-on-monday-whats-going-on">AI software company&#8217;s stock</a>.
AI Momentum: Palantir shares have risen more than 97% year-to-date on the back of AI-related tailwinds. The company continues to see strong demand for its Artificial Intelligence Platform, which has helped it become one of the best-performing names in the S&amp;P 500 in recent years. 
In the words of co-founder and CEO Alex Karp, Palantir is &#8220;delivering the operating system for the modern enterprise in the era of AI.&#8221; Karp said last quarter that the company was in the middle of a &#8220;tectonic shift&#8221; in the adoption of its software.
Palantir beat analyst estimates on the top and bottom lines when it reported <a href="https://www.benzinga.com/news/earnings/25/05/45208000/palantir-q1-earnings-revenue-beat-eps-in-line-customer-count-up-39-company-raises-guidance-citing-surging-and-ferocious-growth">first-quarter results</a> in May. U.S. Commercial revenue increased 71% year-over-year and U.S. Government revenue climbed 45%. 
Palantir&#8217;s customer count also grew 39% year-over-year and 8% on a quarter-over-quarter basis, which included 139 deals worth over $1 million during the first quarter and 51 deals worth at least $5 million.
After the market closed on Monday, Palantir scheduled its second-quarter earnings for after the market close on Aug. 4. Analysts currently expect the company to report earnings of 14 cents per share and revenue of $939.71 million, according to estimates from <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Analysts are divided on where Palantir shares are headed. Some analysts maintained Neutral or Underperform ratings following the company&#8217;s first-quarter results, with price targets as low as $90. Others see more room to run with Loop Capital increasing its price target to $155 last month and Wedbush raising its target to a Street-high $160 last week. 
Wedbush&#8217;s Dan Ives sees a "golden path" forward for Palantir and expects the company to be a "core winner" of the trillions of AI spend anticipated over the next few years.
At the end of May, Ives predicted that Palantir could reach a $1 trillion market cap valuation, or approximately $427 per share, over the next two to three years. 
&#8220;You cannot talk AI revolution without saying Palantir," Ives <a href="https://www.benzinga.com/trading-ideas/movers/25/06/46098312/palantir-stock-hits-all-time-high-whats-going-on">said</a> at the time. 
PLTR Price Action: <a href="http://benzinga.com/quote/pltr">Palantir shares</a> hit a new all-time high of $149.57 in Monday&#8217;s session before closing the day up 4.96% at $149.15, per <a href="http://pro.benzinga.com">Benzinga Pro</a>. Palantir stock is now up approximately 61% over the past three months. The stock has a high momentum score of 98.91, according to Benzinga&nbsp;<a href="https://www.benzinga.com/quote/PLTR" target="_blank" rel="noreferrer noopener">data</a>.&nbsp;
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46400448/dan-ives-bets-on-cybersecurity-as-biggest-subsector-in-tech-for-2025-expects-strong-q2-earnings-from-crowdstrike-zscaler-palo-alto-check-point">Dan Ives Bets On Cybersecurity As &#8216;Biggest Subsector&#8217; In Tech For 2025; Expects Strong Q2 Earnings From CrowdStrike, Zscaler, Palo Alto, Check Point</a></li>
</ul>
Photo: Sundry Photography/Shutterstock.com

PLTR

Palantir Stock Is On Fire, Shares Hit Another All-Time High: What's Fueling The Momentum?

New superhero movie "Superman" won the weekend's box office, coming in ahead of most estimates, which may be all the more impressive given the<a href="https://www.benzinga.com/news/entertainment/25/07/46357567/superman-an-immigrant-superhero-actor-says-warner-bros-film-is-woke-issues-box-office-warning"> call for boycotts</a> over the movie's immigrant plot line.
What Happened: The DC Comics unit of Warner Bros. Discovery (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBD#NASDAQ">WBD</a>) has a new hit film on its hands in hopes that the company's film universe <a href="https://www.benzinga.com/general/entertainment/23/02/30678077/its-a-bird-its-a-plane-its-dc-comics-new-movies-tv-shows-announced">can rise again.</a>
"Superman" grossed $125 million domestically and $95 million during its opening weekend, good for a global haul of $220 million, as reported by <a href="https://variety.com/2025/film/box-office/superman-box-office-opening-weekend-1236459080/">Variety</a>.
The film's domestic total came in line with estimates of $120 million to $130 million ahead of the weekend and beat a $100 million to $110 million estimate from the movie studio.
The opening total of $125 million makes "Superman" the third-highest opening domestically in 2025, trailing only "Minecraft" at $162 million and "Lilo &amp; Stitch" at $146 million. The movie's opening box office also surpasses the $116.0 million from "Man of Steel" in 2013, the last standalone Superman film.
"Superman's" box office totals, coming in ahead of studio estimates and in range with most experts, could be impressive given the criticism the film and director James Gunn faced in recent weeks.
The new superhero movie was called "woke" by actor Dean Cain, who famously played Superman in the TV show "Lois &amp; Clark" from 1993 to 1997.
&#8220;How woke is Hollywood going to make this character?&#8221; Cain told&nbsp;<a href="https://www.tmz.com/2025/07/09/superman-dean-cain-immigrant-controversy/" target="_blank" rel="noreferrer noopener">TMZ</a>. &#8220;How much is Disney going to change their Snow White? Why are they going to change their characters (to) exist for the times?&#8221;
Cain&#8217;s comments, reported by <a href="https://variety.com/2025/film/news/dean-cain-superman-woke-maga-backlash-immigrant-1236451732/" target="_blank" rel="noreferrer noopener">Variety</a>, follow Gunn&#8217;s statement that Superman is an &#8220;immigrant that came from other places and populated the country&#8221; in the film, adding that the film represents &#8220;the story of America.&#8221;
&#8220;For Superman, it was ‘truth, justice, and the American way.&#8217; Well, they dropped that…They came up with ‘truth, justice, and a better tomorrow.&#8217; Changing beloved characters I don&#8217;t think is a great idea. If you want to create a new character go ahead and do that,&#8221; Cain also said.
Cain predicted the immigrant plot line was a mistake that would have financial ramifications.
"I think it's going to hurt the numbers on the movie."
Cain wasn't the only one speaking out about the film's plot line, in which Superman was portrayed as an immigrant. Allies of Donald Trump's Make America Great Again movement called for a boycott over the film's immigration-themed plot.
Fox News has been referencing the film as "SuperWoke" in recent weeks. Fox News contributor Kellyanne Conway criticized the film's plot line.
&#8220;We don&#8217;t go to the movie theater to be lectured to and to have somebody throw their ideology onto us,&#8221; Conway said.
Gunn has brushed off the criticism ahead of the film&#8217;s release.
&#8220;I think this is a movie about kindness and I think that&#8217;s something everyone can relate to,&#8221; Gunn said.
The potential boycott and the film being called woke put pressure on Gunn and Warner Bros. Discovery ahead of the release. Disney previously received criticism for being perceived as "woke" with several recent movie releases, such as "Snow White," which could potentially hurt box office results.
Read Also: <a href="https://www.benzinga.com/general/entertainment/24/12/42750888/top-anticipated-2025-movies-for-big-screen-success-and-stocks-investors-should-watch">Top Anticipated 2025 Movies For Big Screen Success And Stocks Investors Should Watch</a>
Why It's Important: The success of "Superman" in the face of boycotts could bode well for Warner Bros. Discovery.
The film has received positive reactions from critics and fans, which could help the film's box office in the coming weeks. This comes at a cost of $225 million for the film&#8217;s production budget and $100 million for its marketing budget.
Gunn and Peter Safran took over the task of leading DC Studios in 2022 after the Warner unit released several box office duds.
"The DC vision is clear, the momentum is real, and I couldn't be more excited for what's ahead," Warner Bros. Discovery CEO David Zaslav said after the film's success.
The future of DC Studios films includes a 10-year plan of films and spinoffs, such as "Supergirl" and "Clayface," both set for 2026 releases.
Warner Bros. and Zaslav are hoping that Gunn can replicate some of the magic he had with the "Guardians of the Galaxy" franchise for Disney, bringing DC Studios closer to the box office success that the Marvel Cinematic Universe has achieved for Disney.
WBD Price Action: Warner Bros. stock was up 2.4% to $12.01 on Monday versus a 52-week trading range of $6.64 to $12.70.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/07/46299629/amc-declares-war-on-empty-seats-with-50-midweek-discounts-genius-or-desperation">AMC Declares War On Empty Seats With 50% Midweek Discounts—Genius Or Desperation?</a></li>
</ul>
Photo: John B Hewitt / Shutterstock.com

Entertainment

Politics

It's A Bird, It's A Plane, It's A MAGA Boycott Movement Taken Down: Superman Wins Box Office

CHDN

Churchill Downs To Buy 90% Of Casino Salem For $180M

PROK

ProKidney Corp Files For Common Stock Offering Of Up To $200M; Says In The Offering, Co May Offer And Sell Shares Of Class A Common Stock

Management

Newmont Corp Karyn F. Ovelmen Resigns As CFO; Peter Wexler Appointed Interim CFO

<h3>Gainers</h3>
<ul>
<li>Movano (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOVE#NASDAQ">MOVE</a>) shares moved upwards by 45.4% to $0.8 during Monday's after-market session. The company's market cap stands at $4.9 million. </li>
<li>3 E Network (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MASK#NASDAQ">MASK</a>) shares rose 9.58% to $1.6. The company's market cap stands at $21.6 million. </li>
<li>Soluna Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLNH#NASDAQ">SLNH</a>) stock rose 8.1% to $1.2. The company's market cap stands at $27.5 million. </li>
<li>SMX (Security Matters) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMX#NASDAQ">SMX</a>) stock moved upwards by 7.14% to $1.8. The company's market cap stands at $6.0 million. </li>
<li>BIT Mining (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTCM#NYSE">BTCM</a>) stock increased by 5.24% to $4.59. The company's market cap stands at $63.1 million. </li>
<li>Saiheat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAIH#NASDAQ">SAIH</a>) stock moved upwards by 4.92% to $9.8. The company's market cap stands at $13.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>TROOPS (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TROO#NASDAQ">TROO</a>) shares decreased by 19.4% to $1.08 during Monday's after-market session. The company's market cap stands at $66.0 million. </li>
<li>Abits Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABTS#NASDAQ">ABTS</a>) shares decreased by 5.76% to $5.08. The market value of their outstanding shares is at $13.9 million. </li>
<li>ZenaTech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZENA#NASDAQ">ZENA</a>) shares declined by 4.04% to $5.94. The company's market cap stands at $128.2 million. </li>
<li>ACM Research (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACMR#NASDAQ">ACMR</a>) shares fell 3.91% to $27.8. The market value of their outstanding shares is at $1.8 billion. </li>
<li>Blaize Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BZAI#NASDAQ">BZAI</a>) shares declined by 3.45% to $2.8. The company's market cap stands at $285.7 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ABTS

ACMR

BTCM

BZAI

MASK

MOVE

SAIH

SLNH

TROO

ZENA

11 Information Technology Stocks Moving In Monday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Xcel Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XELB#NASDAQ">XELB</a>) stock rose 20.9% to $2.02 during Monday's after-market session. The company's market cap stands at $4.0 million. </li>
<li>Red Robin Gourmet Burgers (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RRGB#NASDAQ">RRGB</a>) stock moved upwards by 10.12% to $6.2. The company's market cap stands at $105.7 million. </li>
<li>MaxsMaking (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAMK#NASDAQ">MAMK</a>) stock moved upwards by 6.86% to $3.27. The market value of their outstanding shares is at $56.0 million. </li>
<li>PetMed Express (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PETS#NASDAQ">PETS</a>) shares rose 4.07% to $3.32. The market value of their outstanding shares is at $68.5 million. </li>
<li>SharpLink Gaming (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBET#NASDAQ">SBET</a>) stock increased by 3.76% to $24.78. The market value of their outstanding shares is at $1.5 billion. </li>
<li>Brightstar Lottery (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRSL#NYSE">BRSL</a>) shares moved upwards by 3.37% to $15.24. The company's market cap stands at $3.6 billion. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Kaival Brands Innovations (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KAVL#NASDAQ">KAVL</a>) stock declined by 24.6% to $0.51 during Monday's after-market session. The company's market cap stands at $6.0 million. </li>
<li>Lobo EV Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOBO#NASDAQ">LOBO</a>) shares decreased by 13.42% to $0.54. The company's market cap stands at $4.2 million. </li>
<li>Autozi Internet Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AZI#NASDAQ">AZI</a>) shares decreased by 9.7% to $0.24. The company's market cap stands at $41.5 million. </li>
<li>Ruanyun Edai Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RYET#NASDAQ">RYET</a>) shares declined by 8.43% to $1.74. The company's market cap stands at $682.4 million. </li>
<li>Newegg Commerce (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEGG#NASDAQ">NEGG</a>) shares decreased by 7.35% to $33.56. The market value of their outstanding shares is at $959.0 million. </li>
<li>Workhorse Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WKHS#NASDAQ">WKHS</a>) stock decreased by 4.28% to $2.69. The company's market cap stands at $41.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BRSL

KAVL

LOBO

MAMK

NEGG

PETS

RRGB

RYET

SBET

WKHS

XELB

12 Consumer Discretionary Stocks Moving In Monday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Quanterix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QTRX#NASDAQ">QTRX</a>) stock rose 7.9% to $6.53 during Monday's after-market session. The company's market cap stands at $274.7 million. </li>
<li>Atlantic International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATLN#NASDAQ">ATLN</a>) stock increased by 7.79% to $2.35. The company's market cap stands at $133.7 million. </li>
<li>AngioDynamics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANGO#NASDAQ">ANGO</a>) stock increased by 7.29% to $10.29. The market value of their outstanding shares is at $378.4 million. </li>
<li>NewGenIvf Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIVF#NASDAQ">NIVF</a>) stock moved upwards by 7.23% to $0.68. The company's market cap stands at $2.7 million. </li>
<li>Acurx Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACXP#NASDAQ">ACXP</a>) shares moved upwards by 7.01% to $0.49. The market value of their outstanding shares is at $11.1 million. </li>
<li>60 Degrees (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SXTP#NASDAQ">SXTP</a>) shares increased by 6.69% to $2.31. The market value of their outstanding shares is at $3.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Organogenesis Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORGO#NASDAQ">ORGO</a>) shares fell 31.0% to $3.1 during Monday's after-market session. The company's market cap stands at $545.4 million. </li>
<li>MiMedx Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDXG#NASDAQ">MDXG</a>) shares fell 20.48% to $5.4. The market value of their outstanding shares is at $981.4 million. </li>
<li>Rani Therapeutics Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RANI#NASDAQ">RANI</a>) shares declined by 14.07% to $0.6. The market value of their outstanding shares is at $25.2 million. </li>
<li>VSee Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSEE#NASDAQ">VSEE</a>) shares fell 12.95% to $1.21. The company's market cap stands at $19.2 million. </li>
<li>Talphera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLPH#NASDAQ">TLPH</a>) stock decreased by 11.86% to $0.42. The company's market cap stands at $10.6 million. </li>
<li>Rallybio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RLYB#NASDAQ">RLYB</a>) shares declined by 8.4% to $0.4. The market value of their outstanding shares is at $16.9 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ACXP

ANGO

ATLN

MDXG

NIVF

ORGO

QTRX

RANI

RLYB

SXTP

TLPH

VSEE

12 Health Care Stocks Moving In Monday's After-Market Session

Health Care

Press Releases

NuCana Presents Encouraging Data on NUC-7738 in Combination with Pembrolizumab in PD-1 Inhibitor Refractory and Resistant Melanoma Patients at the ESMO Congress 2024

Legal

NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in the United States

NuCana Announces Encouraging Initial Data from Phase 1b/2 Modular Study of NUC-3373 in Combination with Pembrolizumab or Docetaxel

Earnings

NuCana Reports Third Quarter 2024 Financial Results and Provides Business Update

Aurion Biotech Appoints Donald Munoz as Chief Financial Officer

NuCana Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Update

NuCana Prices $7 Million Registered Direct Offering

Pennies on the Rise: HCTI, SWISF, ADHC, NCNA Gain Traction Amid LargeCap Uncertainty – More Stocks Inside

NuCana Reports First Quarter 2025 Financial Results and Provides Business Update

Comments

NuCana

Noticias

Últimas noticias sobre NuCana (NASDAQ:NCNA) Bolsa

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL